Skip to content

RETINALGENIX TECHNOLOGIES INC.: 10-Q filed 2022-08-19

What RETINALGENIX TECHNOLOGIES INC. reported in its quarterly report filed 2022-08-19 (fiscal Q2 2022): 20 published measures, 60 facts as tagged in accession 0001493152-22-023602.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-19
Fiscal period
fiscal Q2 2022
Accession
0001493152-22-023602 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All RETINALGENIX TECHNOLOGIES INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-3027USD
At 2021-12-314,947USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-30675,202USD
At 2021-12-31469,622USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-30-675,175USD
At 2022-03-31-724,323USD
At 2021-12-31-464,675USD
At 2021-06-30-35,742USD
At 2021-03-31-254,453USD
At 2020-12-31-80,356USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-06-3027USD
At 2021-12-314,947USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-359,335USD91
2022-01-01 to 2022-06-30-734,534USD181
2022-01-01 to 2022-03-31-375,199USD90
2021-04-01 to 2021-06-30-534,852USD91
2021-01-01 to 2021-06-30-1,218,533USD181
2021-01-01 to 2021-03-31-683,681USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-107,106USD181
2021-01-01 to 2021-06-30-663,726USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-30102,186USD181
2021-01-01 to 2021-06-30662,765USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-5,838,850USD
At 2021-12-31-5,104,316USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-04-01 to 2022-06-3014,523,114shares91
2022-01-01 to 2022-06-3014,400,037shares181
2021-04-01 to 2021-06-3041,034,873shares91
2021-01-01 to 2021-06-3041,083,006shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.02USD/shares91
2022-01-01 to 2022-06-30-0.05USD/shares181
2021-04-01 to 2021-06-30-0.01USD/shares91
2021-01-01 to 2021-06-30-0.03USD/shares181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-04-01 to 2022-06-3055,051USD91
2022-01-01 to 2022-06-30110,102USD181
2021-04-01 to 2021-06-3086,329USD91
2021-01-01 to 2021-06-30197,816USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-06-3027USD
At 2021-12-314,947USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-04-01 to 2022-06-301,460USD91
2022-01-01 to 2022-06-302,920USD181

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-06-30339,579USD
At 2021-12-31251,282USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-30357,875USD91
2022-01-01 to 2022-06-30731,614USD181
2021-04-01 to 2021-06-30534,852USD91
2021-01-01 to 2021-06-301,218,533USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-04-01 to 2022-06-30135,439USD91
2022-01-01 to 2022-06-30292,932USD181
2021-04-01 to 2021-06-30159,941USD91
2021-01-01 to 2021-06-30364,665USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-3014,635,746shares
At 2021-12-3114,221,814shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-06-305,162,156USD
At 2021-12-314,638,218USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30167,385USD91
2022-01-01 to 2022-06-30328,580USD181
2021-04-01 to 2021-06-30288,582USD91
2021-01-01 to 2021-06-30656,052USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-06-3060,500USD181
2021-01-01 to 2021-06-30661,473USD181

Inspect the source

Entity
RETINALGENIX TECHNOLOGIES INC. / CIK 0001836295
Captured
2026-09-21T17:29:46.648Z
SEC response SHA-256
dd1391ce51bf49d231e305a3aac122a3dd931e6d5a5195ef8432fe80b7fd24ad

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001836295.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))